However, despite this clear anti-inflammatory effect in the acute model, treatment with the α7nAChR agonist PHA 568487 did not alter infarct size or cardiac function at 24 h or one week post myocardial infarction. This evidence concerns the gene CHRNA7 and myocardial infarction.